Approval · Notice of Compliance 12105 · 2011
RHOVANE: Notice of Compliance 12105
Issued February 25, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12105
- Date
- February 25, 2011
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hypnotic / Sedative
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RHOVANE | 02008203 | Cancelled Post Market |
Medicinal ingredients
- ZOPICLONE 7.5 MG per TAB